Liminatus Pharma, Inc. Class A Common Stock

LIMN: Is Liminatus Pharma, Inc. Class A Common Stock Halal?

Liminatus Pharma, Inc. Class A Common Stock

NASDAQHealthcareUS

$4.61

-1.28%

Market Cap: 6.2M

Compliance Status

Halal

Screened on Aug 26, 2026 · AAOIFI Standard 21

B+

Good

76Score

Is Liminatus Pharma, Inc. Class A Common Stock (LIMN) halal? Halal. Based on AAOIFI screening, Liminatus Pharma, Inc. Class A Common Stock passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 76/100 (Grade: B+).

Business activity

What the company sells is permissible.

Passed

Company debt

Close to the limit

How much the company borrows, compared to its total value. AAOIFI allows up to 30%.

23.3% of 30.0% limit

What this means for you

You can own LIMN

It passes both the business activity and financial ratio screens under AAOIFI Standard 21.

Purification amount is Pro

We have screened LIMN's prohibited income, but the exact share you would need to purify is part of Pro.

About Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.

Sector: Healthcare · Industry: Biotechnology

Shariah Compliance Status

AAOIFI Standard 21Updated Aug 26, 2026

Compliance History

Halal, unchanged since Aug 2026.

No status changes recorded since we began tracking.

Tracked since Aug 2026. Updates automatically on each re-screen.

Fiscal: FY 2025Data source: FMP
Free · No credit card required

Track LIMN and 6,200+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

6,200+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is Liminatus Pharma, Inc. Class A Common Stock (LIMN) halal to invest in?
Based on AAOIFI Standard 21 screening, Liminatus Pharma, Inc. Class A Common Stock (LIMN) is rated Halal with a compliance grade of B+ (Good). It passes both the business activity screen (no primary involvement in prohibited sectors) and the quantitative financial ratio screen (debt, interest deposits, and prohibited income all below AAOIFI thresholds).
Why did Liminatus Pharma, Inc. Class A Common Stock get a B+ compliance rating?
Liminatus Pharma, Inc. Class A Common Stock (LIMN) received a grade of B+ (Good) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 23.3% (limit 30%). The grade reflects the margin of safety across all three ratios relative to their thresholds.
What could change Liminatus Pharma, Inc. Class A Common Stock's Shariah verdict?
Liminatus Pharma, Inc. Class A Common Stock's verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.
How often is Liminatus Pharma, Inc. Class A Common Stock re-screened for Shariah compliance?
Liminatus Pharma, Inc. Class A Common Stock (LIMN) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Aug 26, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.